Aemetis Inc
NASDAQ:AMTX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.21
6.02
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AMTX stock under the Base Case scenario is 15.22 USD. Compared to the current market price of 4.62 USD, Aemetis Inc is Undervalued by 70%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Aemetis Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AMTX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Aemetis Inc
Balance Sheet Decomposition
Aemetis Inc
Current Assets | 23.9m |
Cash & Short-Term Investments | 234k |
Receivables | 8.8m |
Other Current Assets | 14.9m |
Non-Current Assets | 208.2m |
PP&E | 196.2m |
Other Non-Current Assets | 12m |
Current Liabilities | 120.9m |
Accounts Payable | 28.8m |
Accrued Liabilities | 475k |
Short-Term Debt | 18.8m |
Other Current Liabilities | 72.8m |
Non-Current Liabilities | 360.2m |
Long-Term Debt | 357.6m |
Other Non-Current Liabilities | 2.5m |
Earnings Waterfall
Aemetis Inc
Revenue
|
278.6m
USD
|
Cost of Revenue
|
-279.7m
USD
|
Gross Profit
|
-1.1m
USD
|
Operating Expenses
|
-39.5m
USD
|
Operating Income
|
-40.6m
USD
|
Other Expenses
|
-7.6m
USD
|
Net Income
|
-48.1m
USD
|
Free Cash Flow Analysis
Aemetis Inc
USD | |
Free Cash Flow | USD |
Aemetis reported second-quarter 2024 revenue of $66.6 million, a significant increase from $45.1 million in the same period last year. This growth was driven by their India biodiesel business, which contributed $24.8 million. However, the company faced a gross loss of $1.8 million, compared to a $2 million profit the previous year, largely due to a $3.6 million loss from asset disposal. Operating and net losses also widened. Aemetis remains optimistic, highlighting regulatory developments and positive cash flow from its three main segments. They expect $50 million in annual positive cash flow starting January 2025, driven by new regulatory approvals.
What is Earnings Call?
AMTX Profitability Score
Profitability Due Diligence
Aemetis Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
Aemetis Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
AMTX Solvency Score
Solvency Due Diligence
Aemetis Inc's solvency score is 18/100. The higher the solvency score, the more solvent the company is.
Score
Aemetis Inc's solvency score is 18/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMTX Price Targets Summary
Aemetis Inc
According to Wall Street analysts, the average 1-year price target for AMTX is 14.73 USD with a low forecast of 3.03 USD and a high forecast of 29.4 USD.
Dividends
Current shareholder yield for AMTX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
AMTX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. The company is headquartered in Cupertino, California and currently employs 158 full-time employees. The company went IPO on 2006-06-01. The firm is focused on the acquisition, development and commercialization of negative carbon intensity products and technologies. The Company’s segments include California Ethanol, Dairy Renewable Natural Gas and India Biodiesel. The firm owns and operates approximately 65 million gallon per year ethanol production facility located in Keyes, California (Keyes Plant). In California Ethanol, the Company offers five products at the Keyes Plant: enatured fuel ethanol, wet distiller's grains (WDG), distiller's corn oil (DCO), carbon di- oxide (CO2), and condensed distillers solubles (CDS). In India Biodiesel, the Company producing two products at the Kakinada Plant: biodiesel and refined glycerin produced from further processing of the crude glycerin produced as a by product of the production of biodiesel. Its Aemetis Carbon Zero 1 facility in Riverbank, produces renewable diesel and sustainable aviation fuel.
Contact
IPO
Employees
Officers
The intrinsic value of one AMTX stock under the Base Case scenario is 15.22 USD.
Compared to the current market price of 4.62 USD, Aemetis Inc is Undervalued by 70%.